Prague Medical Report
Journal of First Faculty of Medicine, Charles University, Czech Republic 

Individual author index pages

• Jana Hořínková
• Petr Kozlík
• Tomáš Křížek
• Danica Michaličková
• Martin Šíma
• Ondřej Slanař

Other articles of these authors

• Pregnane Xenobiotic Receptors and Their Effect on Drug Elimination from the Organism

  Martin Šíma*, I. Netíková, O. Slanař

  2013, Vol. 114, Issue 4, pp. 205-213
• Terlipressin Induced Severe Hyponatremia

  Martin Šíma, Miroslav Pokorný, František Paďour, Ondřej Slanař

  2016, Vol. 117, Issue 1, pp. 68-72
• Meropenem-induced Valproic Acid Elimination: A Case Report of Clinically Relevant Drug Interaction

  Martin Šíma, Jan Hartinger, Jan Rulíšek, Robert Šachl, Ondřej Slanař

  2017, Vol. 118, Issue 2-3, pp. 105-109
• 5-fluorouracil Toxicity Mechanism Determination in Human Keratinocytes: in vitro Study on HaCaT Cell Line

  Jan Hartinger, Pavel Veselý, Martin Šíma, Irena Netíková, Eva Matoušková, Luboš Petruželka

  2017, Vol. 118, Issue 4, pp. 128-138
• Gastric pH in Rats: Key Determinant for Preclinical Evaluation of pH-dependent Oral Drug Absorption

  Martin Šíma, Nikolina Kutinová-Canová, Pavel Ryšánek, Jana Hořínková, Denisa Moškořová, Ondřej Slanař

  2019, Vol. 120, Issue 1, pp. 5-9
• Pharmacokinetics of Dasatinib

  Jana Hořínková, Martin Šíma, Ondřej Slanař

  2019, Vol. 120, Issue 2-3, pp. 52-63
• Therapeutic Drug Monitoring of Protein Kinase Inhibitors in Breast Cancer Patients

  Jaroslava Roušarová, Martin Šíma, Ondřej Slanař

  2021, Vol. 122, Issue 4, pp. 243-256
• Factors Affecting Drug Exposure after Inhalation

  Anežka Nováková, Martin Šíma, Ondřej Slanař

  2022, Vol. 123, Issue 3, pp. 129-139
• Therapeutic Drug Monitoring of Protein Kinase Inhibitors in the Treatment of Non-small Cell Lung Cancer

  Judita Staša, Jana Gregorová, Ondřej Slanař, Martin Šíma

  2023, Vol. 124, Issue 3, pp. 199-215
• Effects of Cannabidiol in Inflammation: A Review of Pre-clinical and Clinical Findings

  Michaela Sklenárová, Martin Šíma, Ondřej Slanař

  2023, Vol. 124, Issue 3, pp. 216-229
• Demonstration of the Rationale for Therapeutic Drug Monitoring of Isavuconazole: A Case Report with a Lung Transplant Recipient

  Eliška Dvořáčková, Andrea Zajacová, Jan Havlín, Eva Klapková, Robert Lischke, Ondřej Slanař, Martin Šíma

  2023, Vol. 124, Issue 4, pp. 444-448
• Evidence for Therapeutic Drug Monitoring of Atypical Antipsychotics

  Veronika Krejčí, Irena Murínová, Ondřej Slanař, Martin Šíma

  2024, Vol. 125, Issue 2, pp. 101-129
• Pharmacokinetic-based Dosing Individualization of Mycophenolate Mofetil in Solid Organ Transplanted Patients

  Sara Merdita, Pavel Ryšánek, Jan Miroslav Hartinger, Ondřej Slanař, Martin Šíma

  2024, Vol. 125, Issue 3, pp. 187-194